{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:45:21Z","timestamp":1760204721478},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00520-014-2582-8","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T04:48:54Z","timestamp":1420778934000},"page":"2287-2295","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors for piperacillin\/tazobactam-resistant Gram-negative infection in hematology\/oncology patients with febrile neutropenia"],"prefix":"10.1007","volume":"23","author":[{"given":"Bernard L.","family":"Marini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon M.","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S.","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"Abu-Seir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerod L.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,10]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"crossref","unstructured":"Lyman GH, Rolston KVI (2010) How we treat febrile neutropenia in patients receiving cancer chemotherapy. J Oncol Pract 6(3):149\u201352","DOI":"10.1200\/JOP.091092"},{"issue":"4","key":"2582_CR2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56\u2013e93","journal-title":"Clin Infect Dis"},{"key":"2582_CR3","doi-asserted-by":"crossref","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258\u201366","DOI":"10.1002\/cncr.21847"},{"key":"2582_CR4","doi-asserted-by":"crossref","unstructured":"Vigil KJ, Adachi JA, Aboufaycal H et al (2009) Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Contr 37(9):741\u20135","DOI":"10.1016\/j.ajic.2009.02.002"},{"key":"2582_CR5","doi-asserted-by":"crossref","unstructured":"Horasan ES, Ersoz G, Horoz M, G\u00f6ksu M, Karacorlu S, Kaya A (2011) Risk factors for infections caused by multidrug-resistant bacteria in patients with solid tumours. Scand J Infect Dis 43(2):107\u201311","DOI":"10.3109\/00365548.2010.534500"},{"key":"2582_CR6","doi-asserted-by":"crossref","unstructured":"Gudiol C, Tubau F, Calatayud L et al (2011) Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 66(3):657\u201363","DOI":"10.1093\/jac\/dkq494"},{"key":"2582_CR7","doi-asserted-by":"crossref","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C et al (2010) Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 65(2):333\u201341","DOI":"10.1093\/jac\/dkp411"},{"key":"2582_CR8","doi-asserted-by":"crossref","unstructured":"Garnica M, Maiolino A, Nucci M (2009) Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Braz J Med Biol Res 42(3):289\u201393","DOI":"10.1590\/S0100-879X2009000300010"},{"key":"2582_CR9","doi-asserted-by":"crossref","unstructured":"Micek ST, Welch EC, Khan J et al (2010) Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 54(5):1742\u20138","DOI":"10.1128\/AAC.01365-09"},{"issue":"2","key":"2582_CR10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","volume":"49","author":"CI Kang","year":"2005","unstructured":"Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49(2):760\u2013766","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2582_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"issue":"4","key":"2582_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","volume":"58","author":"EM Trecarichi","year":"2009","unstructured":"Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58(4):299\u2013307","journal-title":"J Infect"},{"issue":"3","key":"2582_CR13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/AAC.46.3.854-858.2002","volume":"46","author":"AD Harris","year":"2002","unstructured":"Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA (2002) Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46(3):854\u2013858","journal-title":"Antimicrob Agents Chemother"},{"key":"2582_CR14","doi-asserted-by":"crossref","unstructured":"Ortega M, Marco F, Soriano A et al (2009) Analysis of 4758 Escherichia coli bacteremia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob\u00a0Chemother 63:568\u2013574","DOI":"10.1093\/jac\/dkn514"},{"issue":"4 Suppl","key":"2582_CR15","doi-asserted-by":"crossref","first-page":"N64","DOI":"10.1097\/00003246-200104001-00002","volume":"29","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK (2001) Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 29(4 Suppl):N64\u2013N68, Review","journal-title":"Crit Care Med"},{"issue":"2","key":"2582_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/NNR.0b013e318199b517","volume":"58","author":"S Ameringer","year":"2009","unstructured":"Ameringer S, Serlin RC, Ward S (2009) Simpson\u2019s paradox and experimental research. Nurs Res 58(2):123\u2013127","journal-title":"Nurs Res"},{"issue":"1","key":"2582_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajic.2013.06.025","volume":"42","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Goldani LZ, dos Santos RP (2014) Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. Am J Infect Control 42(1):74\u201376","journal-title":"Am J Infect Control"},{"key":"2582_CR18","doi-asserted-by":"crossref","unstructured":"Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S (2010) Phase II study of clofarabine\u00a0monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors. J Clin Oncol 28(4):549\u2013555","DOI":"10.1200\/JCO.2009.23.3130"},{"key":"2582_CR19","doi-asserted-by":"crossref","unstructured":"Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, Greiner J, Vey N, Recher C, Ravandi F, Wang ES, Vasconcelles M, Huebner D, Kantarjian HM (2012) Clofarabine plus cytarabine compared with cytarabine alone in\u00a0older patients with relapsed or refractory acute myelogenous leukemia: results\u00a0from the CLASSIC I Trial. J Clin Oncol 30(20):2492\u20132499","DOI":"10.1200\/JCO.2011.37.9743"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2582-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2582-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:09:37Z","timestamp":1559081377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,10]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2582-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,10]]}}}